Longaeva Partners »

Crinetics Pharmaceuticals In shares owned by Longaeva Partners

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.2M 58k 37.42

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Crinetics Pharmaceuticals In

FMR
BlackRock
Farallon Capital Management
Wellington Management Company
Driehaus Capital Management
T. Rowe Price Associates
Vanguard Portfolio Management
Vanguard Capital Management
Jupiter Topco
Henderson Group
Geode Capital Management
Bellevue Group
State Street Corporation
Baker Bros. Advisors
Polar Capital Holdings

View all funds holding Crinetics Pharmaceuticals In